Webcast Shows Use of Impella 2.5 in High-Risk PCI

 

August 12, 2009

August 12, 2009 – Abiomed Inc. said a webcast of an Impella 2.5 procedure performed on an 85-year-old man with multivessel disease at Mount Sinai Medical Center, now available and archived on the Abiomed Web site www.abiomed.com.

The webcast was broadcasted live from Mount Sinai Medical Center on July 21, 2009 and presents a successful high-risk percutaneous coronary intervention (PCI) case with Impella 2.5 support, performed by Samir Sharma, M.D., director of the catheterization lab and interventions, and Annapoorna Kini, M.D., associate professor of the cath lab at Mount Sinai Medical Center.

The patient, an 85-year-old male with multivessel disease, had a left ventricular ejection fraction (LVEF) of 20 percent, while normal LVEF typically ranges from 60–65 percent. Impella 2.5 was inserted to maintain left ventricular support and provide hemodynamic stability. “(Impella) gives operators the confidence to achieve good results without worrying about hemodynamic compromise,” said Dr. Sharma during the webcast.

For more information: www.abiomed.com

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.